MedDataX Logo

Selenium Supplementation in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00186706 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-05-22

No results posted yet for this study

Summary

Does an oral selenium supplement increase blood levels of antioxidants in patients with established, smoking-related lung disease?

Members of our study group recently discovered that elevated levels of the anti-oxidant GPx-1 may be protective against heart disease. We are studying whether selenium supplementation will improve GPx-1 levels.

Conditions

  • Chronic Obstructive Pulmonary Disease
  • Cardiovascular Disease

Interventions

DRUG

Selenium

Sponsors & Collaborators

  • Father Sean O'Sullivan Research Centre

    collaborator UNKNOWN

  • St. Joseph's Health Care London

    lead OTHER

Principal Investigators

  • Marek J Smieja, MD PhD FRCPC · Associate Professor, Dept. of Pathology & Molecular Medicine, McMaster University; Microbiologist & Infectious Disease Physician, Dept. of Laboratory Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2007-11-30
Completion
2007-11-30

Countries

  • Canada

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00186706 on ClinicalTrials.gov